Allied Domecq, North America has appointed two new members to its Independent Marketing Review Board. The company said yesterday (18 January) that Keith Evans and Guillermo Cabanellas will join the third-party review board.

Evans joins the board representing Asia. He currently serves as director, Primary Health Care and Drug Strategies with the South Australian Department of Health, and is a member and immediate chair of the Australian Intergovernmental Committee on Drugs.

Cabanellas joins the board representing Latin America. He currently serves as a partner at Cabanellas, Etchebarne, Kelly & Dell'Oro Maini Abogados. Cabanellas formerly served as the commissioner of the Argentine International Trade Commission.

In a statement, Jim Clerkin, president of Allied Domecq Spirits, North America, said: "We are delighted to have both Mr. Evans and Mr. Cabanellas join our board and are certain their backgrounds and expertise will garner an effective, unbiased review of both our US and global marketing efforts, ensuring we are delivering messages that promote responsible consumption among legal drinking age adults.

"Responsible marketing is vital to our company's reputation and the integrity of our promotional programs.  The added strength of these two appointments to our board helps to ensure we stay true to our global commitment to market our portfolio of products in a socially responsible manner."

The review board serves to advise the company on global marketing activities to assure that it is in full compliance with the Allied Domecq Spirits & Wine Global Marketing Code. In addition to the review, counsel and analysis of Allied Domecq marketing concepts, the board reviews external complaints and concerns from any interested parties, such as non-governmental organisations, competitors and consumers.